Identification and characterization of the human Gb3/CD77 synthase gene promoter

Glycobiology

Volumn 18, Issue 12, 2008, Pages 1028-1035

  Okuda, Tetsuya ^a   Nakayama, Ken Ichi ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Escherichia coli O157; Glycosphingolipid; Glycosyltransferase; Hemolytic uremic syndrome; Promoter

Indexed keywords

ALPHA 1,4 GALACTOSYLTRANSFERASE; CYTOKINE; GALACTOSYLTRANSFERASE; LUCIFERASE; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC TRANSFECTION; HELA CELL; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; SILENCER ELEMENT; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UNTRANSLATED REGION; UPREGULATION; WESTERN BLOTTING;

BASE SEQUENCE; ENDOTHELIAL CELLS; ESCHERICHIA COLI; GALACTOSYLTRANSFERASES; HELA CELLS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; REGULATORY ELEMENTS, TRANSCRIPTIONAL; SHIGA TOXINS; SP1 TRANSCRIPTION FACTOR;

ESCHERICHIA COLI;

EID: 57049110934     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwn082     Document Type: Article

References (34)

1. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA, Miller DM. 1991. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest. 88:1613-1621.
2. Brembeck FH, Rustgi AK. 2000. The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Sp1. J Biol Chem. 275:28230-28239.
3. Dynan WS, Tjian R. 1983. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell. 35:79-87.
4. Furukawa K, Clausen H, Hakomori S, Sakamoto J, Look K, Lundblad A, Mattes MJ, Lloyd KO. 1985. Analysis of the specificity of five murine anti-blood group A monoclonal antibodies, including one that identifies type 3 and type 4 A determinants. Biochemistry. 24:7820-7826.
5. Giraudo E, Primo L, Audero E, Gerber HP, Koolwijk P, Soker S, Klagsbrun M, Ferrara N, Bussolino F. 1998. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its coreceptor neuropilin-1 in human vascular endothelial cells. J Biol Chem. 273:22128-22135.
6. Hakomori SI, Siddiqui B, Li YT, Li SC, Hellerqvist CG. 1971. Anomeric structures of globoside and ceramide trihexoside of human erythrocytes and hamster fibroblasts. J Biol Chem. 246: 2271-2277.
7. Hamanaka R, Kohno K, Seguchi T, Okamura K, Morimoto A, Ono M, Ogata J, Kuwano M. 1992. Induction of low density lipoprotein receptor and a transcription factor SP-1 by tumor necrosis factor in human microvascular endothelial cells. J Biol Chem. 267:13160-13165.
8. Higaki Y, Schullery D, Kawata Y, Shnyreva M, Abrass C, Bomsztyk K. 2002. Synergistic activation of the rat laminin gamma1 chain promoter by the gutenriched Kruppel-like factor (GKLF/KLF4) and Sp1. Nucleic Acids Res. 30:2270-2279.
9. Ichikawa S, Ozawa K, Hirabayashi Y.1998. Molecular cloning and characterization of the mouse ceramide glucosyltransferase gene. Biochem Biophys Res Commun. 253:707-711.
10. Iwamura K, Furukawa K, Uchikawa M, Sojka BN, Kojima Y, Wiels J, Shiku H, Urano T, Furukawa K. 2003. The blood group P1 synthase gene is identical to the Gb3/CD77 synthase gene. A clue to the solution of the P1/P2/p puzzle. J Biol Chem. 278:44429-44438.
11. Jacewicz M, Clausen H, Nudelman E, Donohue-Rolfe A, Keusch GT. 1986. Pathogenesis of shigella diarrhea: XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med. 163:1391-1404.
12. Kang HT, Ju JW, Cho JW, Hwang ES. 2003. Down-regulation of Sp1 activity through modulation of O-glycosylation by treatment with a low glucose mimetic, 2-deoxyglucose. J Biol Chem. 278:51223-51231.
13. Keusch JJ, Manzella SM, Nyame KA, Cummings RD, Baenziger JU. 2000. Cloning of Gb3 synthase, the key enzyme in globo-series glycosphingolipid synthesis, predicts a family of alpha 1, 4-glycosyltransferases conserved in plants, insects, and mammals. J Biol Chem. 275:25315-25321.
14. Kim SW, Lee SH, Kim KS, Kim CH, Choo YK, Lee YC. 2002. Isolation and characterization of the promoter region of the human GM3 synthase gene. Biochim Biophys Acta. 1578:84-89.
15. Kojima Y, Fukumoto S, Furukawa K, Okajima T, Wiels J, Yokoyama K, Suzuki Y, Urano T, Ohta M, Furukawa K. 2000. Molecular cloning of globotriaosylceramide/CD77 synthase, a glycosyltransferase that initiates the synthesis of globo series glycosphingolipids. J Biol Chem. 275:15152-15156.
16. Kolmakova A, Chatterjee S. 2005. Platelet derived growth factor recruits lactosylceramide to induce cell proliferation in UDP Gal:GLcCer: Beta1 → 4Galactosyltransferase (GalT-V) mutant Chinese hamster ovary cells. Glycoconj J. 22:401-407.
17. Lingwood CA, Law H, Richardson S, Petric M, Brunton JL, De Grandis S, Karmali M. 1987. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem. 262:8834-8839.
18. Marcus DM, Kundu SK, Suzuki A. 1981. The P blood group system: Recent progress in immunochemistry and genetics. Semin Hematol. 18:63-71.
19. Makita A. 1964. Biochemistry of organ glycolipids: II. Isolation of human kidney glycolipids. J Biochem. 55:269-276.
20. Noris M, Remuzzi G. 2005. Hemolytic uremic syndrome. J Am Soc Nephrol 16:1035-1050.
21. Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L, Daniel TO. 1993. Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem. 268:15484-15488.
22. Okuda T, Tokuda N, Numata S, Ito M, Ohta M, Kawamura K, Wiels J, Urano T, Tajima O, Furukawa K, et al. 2006. Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J Biol Chem 281:10230-10235.
23. Ray R, Snyder RC, Thomas S, Koller CA, Miller DM. 1989. Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest. 83:2003-2007.
24. Sato T, Furukawa K. 2004. Transcriptional regulation of the human beta-1,4- galactosyltransferase V gene in cancer cells: Essential role of transcription factor Sp1. J Biol Chem. 279:39574-39583.
25. Shie JL, Chen ZY, Fu M, Pestell RG, Tseng CC. 2000. Gut-enriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res. 28:2969-2976.
26. Spengler ML, Brattain MG. 2006. Sumoylation inhibits cleavage of Sp1 N-terminal negative regulatory domain and inhibits Sp1-dependent transcription. J Biol Chem. 281:5567-5574.
27. Steffensen R, Carlier K, Wiels J, Levery SB, Stroud M, Cedergren B, Nilsson Sojka B, Bennett EP, Jersild C, Clausen H. 2000. Cloning and expression of the histo-blood group Pk UDP-galactose: Ga1beta-4G1cbeta1-cer alpha1, 4-galactosyltransferase. Molecular genetic basis of the p phenotype. J Biol Chem. 275:16723-16729.
28. Stricklett PK, Hughes AK, Kohan DE. 2005. Inhibition of p38 mitogen-activated protein kinase ameliorates cytokine up-regulated shigatoxin-1 toxicity in human brain microvascular endothelial cells. J Infect Dis. 191:461-471.
29. van de Kar NC, Monnens LA, Karmali MA, van Hinsbergh VW. 1992. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: Implications for the pathogenesis of the hemolytic uremic syndrome. Blood. 80:2755-2764.
30. Wiels J, Fellous M, Tursz T. 1981. Monoclonal antibody against a Burkitt lymphoma-associated antigen. Proc Natl Acad Sci USA. 78:6485-6488.
31. Yang X, Su K, Roos MD, Chang Q, Paterson AJ, Kudlow JE. 2001. O Linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci USA. 98:6611-6616.
32. Zeng G, Gao L, Xia T, Tencomnao T, Yu RK. 2003. Characterization of the 5′-flanking fragment of the human GM3-synthase gene. Biochim Biophys Acta. 1625:30-1635.
33. Zhang F, Su K, Yang X, Bowe DB, Paterson AJ, Kudlow JE. 2003. O GlcNAc modification is an endogenous inhibitor of the proteasome. Cell. 115:715-725.
34. Zhang W, Shields JM, Sogawa K, Fujii-Kuriyama Y, Yang VW. 1998. The gut-enriched Krüppel-like factor suppresses the activity of the CYP1A1 promoter in an Sp1-dependent fashion. J Biol Chem. 273:17917-17925.